Save the Date! CardioInterv 2025 – 25th International Symposium on Interventional Cardiology is Coming

From November 26 to 28, 2025, the 25th International Symposium on Interventional Cardiology – CardioInterv 2025 will take place, a scientific excellence event that celebrates 25 years of history and is institutionally sponsored by SOLACI.

November 26, 27, and 28, 2025
Hybrid format: in-person and online

For three days, leading experts in interventional cardiology from Brazil, Latin America, and around the world will gather to:

  • Present live cases
  • Share lectures, talks, and round tables
  • Debate the latest controversies
  • Explore the future of transcatheter therapies

Save the date and be part of this unforgettable edition!

CardioInterv 2025

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

V International Course on Cardiovascular Interventionism – SOLACI Scientific Endorsement

The Latin American Society of Interventional Cardiology (SOLACI) proudly grants its scientific endorsement to the V International Course on Cardiovascular Interventionism, an important academic...

Invitation of the MIL Group to RISE at the ESC 2024 Congress

The Group of Latin American Interventional Women invites you to participate in the next RISE, a professional development conference for women in cardiology promoted...

Artificial Intelligence in Complex PCI Cases – 2nd International Symposium of Cardiology

The Latin American Society of Interventional Cardiology invites the whole community to take part in the 2nd International Symposium of Cardiology entitled “Artificial Intelligence...

SOLACI@PCR Joint Session at EuroPCR 2024 – See You in Paris on May 14 thru 17

The Latin American Society of Interventional Cardiology will once more say here at EuroPCR 2024, undoubtedly one of the most relevant international meetings in...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Clinical and haemodynamic outcomes with contemporary intra- vs. supra-annular valves: The HERA-TAVI Registry

According to the latest European guidelines, transcatheter aortic valve implantation (TAVI) is the recommended treatment for patients aged ≥70 years with symptomatic severe aortic...

Redo-TAVI with SAPIEN 3: 30-Day Outcomes

The indications for transcatheter aortic valve implantation (TAVI) have rapidly expanded to include intermediate- and low-risk patients, extending its use to younger individuals with...

DAPT ≤30 Days After Drug-Coated Balloon Coronary Angioplasty

Drug-coated balloon (DCB) coronary angioplasty without stent implantation has become a well-established alternative in several clinical scenarios, particularly in patients at high bleeding risk...